| Detected | Trial | Change |
|---|---|---|
| 2026-06-12 | NCT07034261 Continuous Glucose Monitoring to Detect Postpartum Dysglycemia in Patients With… |
date change Primary completion pushed: 2026-06 -> 2027-09 |
| 2026-06-12 | NCT07034261 Continuous Glucose Monitoring to Detect Postpartum Dysglycemia in Patients With… |
date change Completion pushed: 2026-09 -> 2027-09 |
| 2026-06-09 | NCT06618794 Recovery Legal Care Clinical Trial |
date change Primary completion pushed: 2026-08-31 -> 2027-08-31 |
| 2026-06-06 | NCT03011671 Study of Acetazolamide With Temozolomide in Adults With Newly Diagnosed or Recurrent… |
date change Primary completion pushed: 2025-06-26 -> 2026-12 |
| 2026-06-06 | NCT06868121 AYA OMGYES Sexual Health Study |
date change Primary completion pushed: 2026-05-01 -> 2026-08-01 |
| 2026-06-06 | NCT06868121 AYA OMGYES Sexual Health Study |
date change Completion pushed: 2026-05-01 -> 2026-11-01 |
| 2026-05-28 | NCT05626452 PrEP Optimization Among Women to Enhance Retention and Uptake |
Trial completed |
| 2026-05-28 | NCT05626452 PrEP Optimization Among Women to Enhance Retention and Uptake |
date change Completion moved earlier: 2026-06 -> 2026-04-30 |
| 2026-05-20 | NCT05337514 Voice-Activated Technology to Improve Mobility in Multimorbid, Frail, Homebound Older… |
date change Primary completion moved earlier: 2026-03-31 -> 2025-05-31 |
| 2026-05-15 | NCT05357066 Nitrous Oxide as Treatment for Fibromyalgia |
overall status: "Recruiting" → "Withdrawn" |
| 2026-05-15 | NCT05357066 Nitrous Oxide as Treatment for Fibromyalgia |
critical why stopped: null → "PI has left university" |
| 2026-05-15 | NCT05357066 Nitrous Oxide as Treatment for Fibromyalgia |
Enrollment reduced: 50 -> 0 participants |
| 2026-05-15 | NCT05357066 Nitrous Oxide as Treatment for Fibromyalgia |
date change Primary completion moved earlier: 2027-06-01 -> 2026-02-27 |
| 2026-05-15 | NCT05357066 Nitrous Oxide as Treatment for Fibromyalgia |
date change Completion moved earlier: 2027-12-01 -> 2026-02-27 |
| 2026-05-15 | NCT05357040 Antidepressant Effects of Nitrous Oxide |
overall status: "Recruiting" → "Withdrawn" |
| 2026-05-15 | NCT05357040 Antidepressant Effects of Nitrous Oxide |
critical why stopped: null → "PI has left the university" |
| 2026-05-15 | NCT05357040 Antidepressant Effects of Nitrous Oxide |
Enrollment reduced: 172 -> 0 participants |
| 2026-05-15 | NCT05357040 Antidepressant Effects of Nitrous Oxide |
date change Primary completion moved earlier: 2026-10-01 -> 2026-02-27 |
| 2026-05-15 | NCT05357040 Antidepressant Effects of Nitrous Oxide |
date change Completion moved earlier: 2026-12-01 -> 2026-02-27 |
| First Posted | Trial | Phase | Status |
|---|---|---|---|
| 2026-06-09 | NCT07636213 BRIDGE-US: Bridging Readiness in Deployed Neurotrauma Gaps for Excellence | Not Yet Recruiting | |
| 2026-05-22 | NCT07603856 A Study Evaluating The Combination of Immunotherapy With Radiotherapy in Non-Small Cell… | Phase 2 | Not Yet Recruiting |
| 2026-05-18 | NCT07592000 Breakthrough - T1DM and Chronic Kidney Disease | Phase 1/2 | Recruiting |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 4 | |||
| NCT02118467 | Vasoactive Drugs in Intensive Care Unit | Shock | Recruiting |
| NCT04479072 | Aspirin and Preeclampsia | Preeclampsia Postpartum | Recruiting |
| NCT06660862 | Evaluating Treatment Outcomes Using Darolutamide and Androgen Deprivation Therapy in… | Prostate Cancer | Not Yet Recruiting |
| Phase 3 | |||
| NCT02659293 | Trial of Carfilzomib, Lenalidomide, Dexamethasone Versus Lenalidomide Alone After… | Multiple Myeloma | Active, Not Recruiting |
| NCT03729804 | Carfilzomib, Lenalidomide, and Dexamethasone Versus Bortezomib, Lenalidomide and… | Multiple Myeloma | Active, Not Recruiting |
| Phase 2/3 | |||
| NCT05796752 | Behavioral Treatment and Memantine in Body Focused Repetitive Behaviors | Skin-Picking | Active, Not Recruiting |
| Phase 2 | |||
| NCT02747303 | Frameless Stereotactic Radiosurgery for Intact Brain Metastases | Brain Metastases | Recruiting |
| NCT07290621 | Toripalimab in Combination With Standard Treatment for Human Papillomavirus (HPV)… | Oropharyngeal Cancer | Recruiting |
| NCT06291064 | Trial Studying Chemotherapy in Nigerian Women With Triple Negative Breast Cancer | Triple Negative Breast Cancer | Recruiting |
| NCT06348134 | Assessing the Efficacy and Safety of Anti-HER2 Therapy in Nigerian Women With HER2+… | Human Epidermal Growth Factor 2 Negative Carcinoma of Breast | Recruiting |
| NCT05068232 | Durvalumab and Ablative Radiation in Small Cell Lung Cancer (DARES) | Small-cell Lung Cancer | Recruiting |
| NCT05726292 | A Study of Enzalutamide Plus the Glucocorticoid Receptor Antagonist Relacorilant Versus… | Prostate Cancer | Recruiting |
| NCT07065630 | Response-Adaptive Treatment in Untreated Locoregional HPV-Negative Head and Neck Cancer | Head and Neck Cancer | Recruiting |
| NCT05640271 | Tocilizumab for Acute Chest Syndrome | Sickle Cell Disease | Recruiting |
| NCT06669572 | Lenvatinib and Pembrolizumab to Treat Patients With Anal or Rectum Cancer That Has Gotten… | Carcinoma, Squamous Cell | Recruiting |
| NCT05420948 | A Study of Pembrolizumab in Combination With Chemotherapy for Head and Neck Cancer | Head and Neck Cancer | Recruiting |
| NCT06191198 | Communication Bridge 3 Study | Primary Progressive Aphasia | Recruiting |
| NCT04747912 | Study of Chemotherapy-Free Induction Regimen for Ph+ Acute Lymphoblastic Leukemia With… | Lymphoblastic Leukemia | Recruiting |
| NCT04107077 | Phase II Study of the Effects of Laparoscopic Hyperthermic Intraperitoneal Chemotherapy… | Gastric Cancer | Recruiting |
| NCT07126561 | Trastuzumab Deruxtecan to Treat HER2 + Newly Diagnosed Metastatic GI Cancers | HER2 Positive Newly Diagnosed Metastatic Esophageal, Gastric, GEJ Cancer Patients With an ECOG Performance Status of 2 | Not Yet Recruiting |
| NCT07346196 | A Trial of Locoregionally Advanced Squamous Cell Carcinoma of The Head and Neck | Squamous Cell Carcinoma | Not Yet Recruiting |
| NCT03879577 | Assessing the Response Rate of Neo-adjuvant Taxotere and Trastuzumab in Nigerian Women… | Breast Cancer | Active, Not Recruiting |
| NCT07179315 | A Study Comparing Two Immunotherapy Options for Human Papillomavirus Positive… | Head and Neck Cancer | Not Yet Recruiting |
| NCT03360890 | Pembrolizumab With Chemotherapy for Poorly Chemo-responsive Thyroid and Salivary Gland… | Thyroid Cancer | Active, Not Recruiting |
| NCT03500445 | Daratumumab, Carfilzomib, Lenalidomide and Low Dose Dexamethasone (DKRd) in Newly… | Myeloma | Active, Not Recruiting |